QSQuantSignals Research/Studies
Try FST free

← All studies

FAIL

Cheap far-out-of-the-money options on 20 large US names: calls, puts and long-dated quiet-volatility buys

Does buying cheap out-of-the-money options pay after costs on 20 large US names, and do 12-24-month calls bought when a name's 60-day realised volatility is in its bottom decile do better?

Nine of the ten pre-registered trials failed. The one pass is calls 10% out of the money, 60-120 days, bought on the first trading day of each month from January 2019 to June 2025 on 20 large US names: 1,414 trades, +50.1% mean return on premium after costs, 99.5% band [+11.7%, +95.7%], 27% of trades profitable. That is near-the-money, not the 'cheap far out of the money' idea: calls 30% and 50% out of the money averaged +11.0% and -24.5%, puts lost 9.9% to 27.3%, and every one of those bands includes zero, so each fails on its lower bound. The top tenth of the 10%-out-of-the-money trades produced 1.74 times the total return, so the other nine-tenths lost money. The long-dated quiet-volatility calls (12-24 months, only when 60-day realised volatility was in the name's bottom decile) averaged +120.8% at 25% out of the money and +166.5% at 50%, on 34 trades over 16 entry dates, with bands that include zero; 9 of the 34 trades in each of the two long-dated call tests were still open when the data ended and were marked at their last quoted bid, not settled, and those marks include the largest returns. The partial put test had 3 trades, fewer than the 30 the bar needs, and lost 93.3%. The pass is judged at the ten pre-registered trials, not at the 2,965 trials QS Research had run when the report was built; at that count the same lower bound is -8.4%. The 20 names are survivors picked in 2026, and the window is mostly a bull market, so the 10% pass is leveraged long beta, not a trading conclusion.

One of the ten pre-registered trials passed: calls 10% out of the money, 60-120 days, on 1,414 trades from January 2019 to June 2025, at +50.1% mean return on premium with a 99.5% band of [+11.7%, +95.7%]. The study itself reports that as near-the-money leveraged long beta on a survivor list in a bull market, not a trading conclusion. The question was about cheap far-out-of-the-money options: calls 30% and 50% out of the money and puts 10-30% out of the money all failed, as did both long-dated quiet-volatility call tests and the partial put test. The headline verdict is fail.

Backtested by QS Research

Pre-registration

Ten trials were fixed before any option quote was read. Seven are monthly entries on the first trading day of January 2019 to June 2025, held to expiry: calls 10%, 20%, 30% and 50% out of the money and puts 10%, 20% and 30% out of the money, 60-120 days, bought at the ask plus $0.0065 a share, with asks under $0.05 skipped. Two are long-dated quiet-volatility call tests: 12-24-month calls 25% and 50% out of the money, entered only when the name's 60-day realised volatility was in the bottom tenth of its trailing three years, from 2016, held to expiry; the first such entry is August 2018, because the percentile needs three years of history. The tenth is a partial version of the same idea on puts 30% out of the money, only on names up at least 50% over the previous 12 months, with the valuation filter left out. Each trial is judged on at least 30 trades, a positive mean after costs, a positive one-sided bootstrap lower bound at 0.05/10 resampling entry dates, and positive skew. The universe is the 20 large US names still listed in 2026: a survivor list, which flatters calls, stated before the run.

Registered 2026-10-29

Trials · 10 trials · 1 passed · judged at N = 10 trials; 2965 trials run in total

TrialVerdict
quick-c10PASScounted
quick-c20FAILcounted
quick-c30FAILcounted
quick-c50FAILcounted
quick-p10FAILcounted
quick-p20FAILcounted
quick-p30FAILcounted
r3-25FAILcounted
r3-50FAILcounted
r3b-partialFAILcounted

Limitations

The numbers: every trial's checks, metrics, curve and yearly results, and the provenance

1 published version · current e3f7fce408ce8e00, published 2026-11-21

Put these signals to work

This page is free. Members get the live version of every QS Research signal. FST, the QuantSignals trading agent, uses QS Research as its brain.

Join freeMeet FSTSee plans